BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hinds TD Jr, Stec DE. Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health. Curr Hypertens Rep 2019;21:87. [PMID: 31599366 DOI: 10.1007/s11906-019-0994-z] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
Number Citing Articles
1 Mancuso C. Biliverdin reductase as a target in drug research and development: Facts and hypotheses. Free Radic Biol Med 2021;172:521-9. [PMID: 34224815 DOI: 10.1016/j.freeradbiomed.2021.06.034] [Reference Citation Analysis]
2 Hinds TD Jr, Creeden JF, Gordon DM, Spegele AC, Britton SL, Koch LG, Stec DE. Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1. Antioxidants (Basel) 2020;9:E889. [PMID: 32961782 DOI: 10.3390/antiox9090889] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
3 Hinds TD Jr, Creeden JF, Gordon DM, Stec DF, Donald MC, Stec DE. Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate. Front Pharmacol 2020;11:594574. [PMID: 33390979 DOI: 10.3389/fphar.2020.594574] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
4 Peterson SJ, Choudhary A, Kalsi AK, Zhao S, Alex R, Abraham NG. OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention. Diagnostics (Basel) 2020;10:E976. [PMID: 33233550 DOI: 10.3390/diagnostics10110976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Creeden JF, Gordon DM, Stec DE, Hinds TD Jr. Bilirubin as a metabolic hormone: the physiological relevance of low levels. Am J Physiol Endocrinol Metab 2021;320:E191-207. [PMID: 33284088 DOI: 10.1152/ajpendo.00405.2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
6 Tan H, Liao S, Pan T, Zhang J, Chen J. Rapid and simultaneous analysis of direct and indirect bilirubin indicators in serum through reagent-free visible-near-infrared spectroscopy combined with chemometrics. Spectrochim Acta A Mol Biomol Spectrosc 2020;233:118215. [PMID: 32151990 DOI: 10.1016/j.saa.2020.118215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
7 Jonaitis T, Lewis EA, Lourens N, Groot A, Goodman RE, Mitchell D, Karpol A, Tracy B. Subchronic feeding, allergenicity, and genotoxicity safety evaluations of single strain bacterial protein. Food and Chemical Toxicology 2022;162:112878. [DOI: 10.1016/j.fct.2022.112878] [Reference Citation Analysis]
8 Thomas DT, Delcimmuto NR, Flack KD, Stec DE, Hinds TD. Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin. Antioxidants 2022;11:179. [DOI: 10.3390/antiox11020179] [Reference Citation Analysis]
9 Croce AC, Ferrigno A, Bottiroli G, Di Pasqua LG, Berardo C, Vairetti M. Fluorescence excitation properties of bilirubin in solution and in serum. J Photochem Photobiol B 2021;215:112121. [PMID: 33422899 DOI: 10.1016/j.jphotobiol.2020.112121] [Reference Citation Analysis]
10 Dvořák A, Pospíšilová K, Žížalová K, Capková N, Muchová L, Vecka M, Vrzáčková N, Křížová J, Zelenka J, Vítek L. The Effects of Bilirubin and Lumirubin on Metabolic and Oxidative Stress Markers. Front Pharmacol 2021;12:567001. [PMID: 33746746 DOI: 10.3389/fphar.2021.567001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Nocentini A, Bonardi A, Pratesi S, Gratteri P, Dani C, Supuran CT. Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin. J Enzyme Inhib Med Chem 2022;37:487-501. [PMID: 34986721 DOI: 10.1080/14756366.2021.2020773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bianco A, Pinci S, Tiribelli C, Bellarosa C. Life-Long Hyperbilirubinemia Exposure and Bilirubin Priming Prevent In Vitro Metabolic Damage. Front Pharmacol 2021;12:646953. [PMID: 33776779 DOI: 10.3389/fphar.2021.646953] [Reference Citation Analysis]
13 Stec DE, Gordon DM, Nestor-Kalinoski AL, Donald MC, Mitchell ZL, Creeden JF, Hinds TD Jr. Biliverdin Reductase A (BVRA) Knockout in Adipocytes Induces Hypertrophy and Reduces Mitochondria in White Fat of Obese Mice. Biomolecules 2020;10:E387. [PMID: 32131495 DOI: 10.3390/biom10030387] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
14 Michael OS, Dibia CL, Adeyanju OA, Olaniyi KS, Areola ED, Olatunji LA. Estrogen-progestin oral contraceptive and nicotine exposure synergistically confers cardio-renoprotection in female Wistar rats. Biomed Pharmacother 2020;129:110387. [PMID: 32540646 DOI: 10.1016/j.biopha.2020.110387] [Reference Citation Analysis]
15 Bianco A, Tiribelli C, Bellarosa C. Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease. Biomedicines 2022;10:696. [DOI: 10.3390/biomedicines10030696] [Reference Citation Analysis]
16 Gordon DM, Hong SH, Kipp ZA, Hinds TD Jr. Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha). Molecules 2021;26:2975. [PMID: 34067839 DOI: 10.3390/molecules26102975] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fang S, Wade KH, Hughes DA, Fitzgibbon S, Yip V, Timpson NJ, Corbin LJ. A multivariant recall‐by‐genotype study of the metabolomic signature of BMI. Obesity. [DOI: 10.1002/oby.23441] [Reference Citation Analysis]
18 Yin S, Xu Y, Wang Z, Wei Z, Xu T, Zhao W, Zhao C. Molecularly-imprinted hydrogel beads via self-sacrificing micro-reactors as safe and selective bilirubin adsorbents. J Mater Chem B 2021. [PMID: 34786576 DOI: 10.1039/d1tb01895g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gordon DM, Neifer KL, Hamoud AA, Hawk CF, Nestor-Kalinoski AL, Miruzzi SA, Morran MP, Adeosun SO, Sarver JG, Erhardt PW, McCullumsmith RE, Stec DE, Hinds TD Jr. Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α. J Biol Chem 2020;295:9804-22. [PMID: 32404366 DOI: 10.1074/jbc.RA120.013700] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
20 McClung JA, Levy L, Garcia V, Stec DE, Peterson SJ, Abraham NG. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications. Pharmacol Ther 2021;:107975. [PMID: 34499923 DOI: 10.1016/j.pharmthera.2021.107975] [Reference Citation Analysis]
21 Ge X, Liu Z, Hou Q, Huang L, Zhou Y, Li D, Huang S, Luo X, Lv Y, Li L, Cheng H, Chen X, Zan G, Tan Y, Liu C, Zou Y, Yang X. Plasma metals and serum bilirubin levels in workers from manganese-exposed workers healthy cohort (MEWHC). Environ Pollut 2020;258:113683. [PMID: 31838386 DOI: 10.1016/j.envpol.2019.113683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
22 Stec DE, Wegiel B, Hinds TD Jr. Editorial: Oxidative Stress, Antioxidants, Transcription Factors, and Assimilation of Signal Transduction Pathways in Obesity-Related Disorders. Front Pharmacol 2021;12:759468. [PMID: 34557106 DOI: 10.3389/fphar.2021.759468] [Reference Citation Analysis]